HIV-1-infection
Showing NaN - NaN of 12
HIV-1-infection Trial in United States (CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg)
Not yet recruiting
- HIV-1-infection
- CVC 150 mg
- +3 more
-
Los Angeles, California
- +16 more
Nov 22, 2022
HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)
Active, not recruiting
- HIV-1-infection
- Oral Lenacapavir
- +4 more
-
Los Angeles, California
- +74 more
Oct 17, 2022
The Visceral Adiposity Measurement and Observation Study
Recruiting
- HIV
- +18 more
- Diagnostic Test
- HIV Anti-retroviral Background Therapy
-
Los Angeles, California
- +5 more
Sep 21, 2022
HIV-1-infection Trial in Los Angeles (Elsulfavirine)
Recruiting
- HIV-1-infection
-
Los Angeles, CaliforniaAltasciences Clinical Los Angeles, Inc.
Apr 11, 2022
HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)
Completed
- HIV-1-infection
- PENNVAX-GP
- +3 more
-
Los Angeles, California
- +1 more
Apr 4, 2022
Methamphetamine-dependence, HIV-1-infection Trial in Los Angeles (Contingency Management-ART, Contingency
Completed
- Methamphetamine-dependence
- HIV-1-infection
- Contingency Management-ART
- Contingency Management-Methamphetamine
-
Los Angeles, CaliforniaUCLA Vine Street Clinic
Sep 27, 2021
Specimen Repository for HIV Immunopathogenesis
Completed
- HIV-1-infection
- Acute HIV Infection
-
Los Angeles, CaliforniaAIDS Healthcare Foundation - Public Health Division
Jan 11, 2021
HIV-1 Reservoir in Central Nervous System of
Completed
- HIV-1-infection
-
Los Angeles, California
- +11 more
Jul 7, 2020
HIV-1-infection, Gut Inflammation Trial in Los Angeles (Pentasa vs Align)
Completed
- HIV-1-infection
- Gut Inflammation
- Pentasa vs Align
-
Los Angeles, CaliforniaAIDS Healthcare Foundation - Public Health Division
Mar 2, 2020